Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
about
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentHeart diastolic dysfunction in patients with systemic sclerosis.Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signaturesRisk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
P2860
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@en
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@nl
type
label
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@en
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@nl
prefLabel
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@en
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@nl
P2093
P356
P1433
P1476
Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
@en
P2093
Daniela Marasovic-Krstulovic
Dijana Perkovic
Dusanka Martinovic-Kaliterna
Ilza Salamunic
Leida Tandara
Vedran Carevic
Zrinka Jurisic
P304
P356
10.1093/RHEUMATOLOGY/KET131
P577
2013-03-27T00:00:00Z